Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

A CDC panel is reconsidering the birth dose for the hepatitis B vaccine. Renewed doubt could lead to fewer kids getting ...

Vaccine advisers to the US Centers for Disease Control and Prevention may vote this week to make a major change to the ...

The nation's top vaccine advisory panel is expected to debate on Thursday whether to delay the first dose of the hepatitis B ...

Mental health conditions are common among veterans and may play a larger role than previously recognized in raising liver ...

Richard Angell, CEO of the Terrence Higgins Trust, considers the success of opt-out HIV testing in A&E – and what it could ...

Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...

As the festive season begins, health officials across Europe share tips to stay safe amid the revelry. View on euronews ...

Delaying the timing of vaccinating infants against hepatitis B — which ACIP could vote on later this week — would likely lead ...

The new chair of the Advisory Committee on Immunization Practices said the panel plans to vote to end universal hepatitis B ...